1. Application of single-port video-assisted thoracoscope in treating thoracic oesophageal squamous cell carcinoma using McKeown approach
- Author
-
Gui-Qing Zeng, Wu-Zhi Wei, Xiaodong Li, Wen-Qiang Lv, Wei-Bin Wu, and Wenke Yang
- Subjects
medicine.medical_specialty ,lcsh:Surgery ,Anastomosis ,03 medical and health sciences ,0302 clinical medicine ,Port (medical) ,medicine ,Basal cell ,Video assisted ,lcsh:RC799-869 ,Laparoscopy ,Thoracoscope ,medicine.diagnostic_test ,treatment ,business.industry ,Stomach ,McKeown approach ,lcsh:RD1-811 ,Surgery ,medicine.anatomical_structure ,oesophageal squamous cell carcinoma ,Cardiothoracic surgery ,030220 oncology & carcinogenesis ,030211 gastroenterology & hepatology ,Original Article ,lcsh:Diseases of the digestive system. Gastroenterology ,business ,single-port video-assisted thoracoscope - Abstract
Objective: This study aims to investigate the feasibility of single-port video-assisted thoracoscope (SPVATS) in treating thoracic oesophageal squamous cell carcinoma (TESCC) using McKeown approach. Materials and Methods: Totally 10 McKeown approach-based SPVATS surgeries (8 males and 2 females, aged 42–68 years) were carried out from January 2015 to December 2015 to treat TESCC, including one case in upper thoracic segment, 5 cases in median thoracic segment and 4 cases in inferior thoracic segment. All the cases were pathologically diagnosed as SCC pre-operatively. SPVATS was performed to free thoracic oesophagus and dissect the lymph nodes, and laparoscopy was performed to free stomach and to perform oesophagus-left gastric collum anastomosis. Results: All the patients were successfully completed SPVATS, with average thoracic surgery time as 150 min, intra-operative blood loss as 30–260 ml (average 90 ml), and post-operative hospital stay as 9–16 days (average 12 days). Conclusions: SPVATS was technically feasible and safe in treating TESCC using McKeown approach, with less trauma and rapid post-operative recovery, and hence, it could be used as a new surgical option for McKeown approach-based TESCC treatment.
- Published
- 2018